244 related articles for article (PubMed ID: 19109159)
1. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.
Jirmo AC; Nagel CH; Bohnen C; Sodeik B; Behrens GM
J Immunol; 2009 Jan; 182(1):283-92. PubMed ID: 19109159
[TBL] [Abstract][Full Text] [Related]
2. Effective Priming of Herpes Simplex Virus-Specific CD8
Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130
[TBL] [Abstract][Full Text] [Related]
3. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.
Jelinek I; Leonard JN; Price GE; Brown KN; Meyer-Manlapat A; Goldsmith PK; Wang Y; Venzon D; Epstein SL; Segal DM
J Immunol; 2011 Feb; 186(4):2422-9. PubMed ID: 21242525
[TBL] [Abstract][Full Text] [Related]
4. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
Tabi Z; Moutaftsi M; Borysiewicz LK
J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
[TBL] [Abstract][Full Text] [Related]
5. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1.
Smith CM; Belz GT; Wilson NS; Villadangos JA; Shortman K; Carbone FR; Heath WR
J Immunol; 2003 May; 170(9):4437-40. PubMed ID: 12707318
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.
Bosnjak L; Miranda-Saksena M; Koelle DM; Boadle RA; Jones CA; Cunningham AL
J Immunol; 2005 Feb; 174(4):2220-7. PubMed ID: 15699155
[TBL] [Abstract][Full Text] [Related]
7. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.
Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC
J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225
[TBL] [Abstract][Full Text] [Related]
8. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
[TBL] [Abstract][Full Text] [Related]
9. Cutting edge: conventional CD8 alpha+ dendritic cells are generally involved in priming CTL immunity to viruses.
Belz GT; Smith CM; Eichner D; Shortman K; Karupiah G; Carbone FR; Heath WR
J Immunol; 2004 Feb; 172(4):1996-2000. PubMed ID: 14764661
[TBL] [Abstract][Full Text] [Related]
10. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.
Win SJ; Ward VK; Dunbar PR; Young SL; Baird MA
Immunol Cell Biol; 2011 Aug; 89(6):681-8. PubMed ID: 21221122
[TBL] [Abstract][Full Text] [Related]
11. Serpinb9 (Spi6)-deficient mice are impaired in dendritic cell-mediated antigen cross-presentation.
Rizzitelli A; Meuter S; Vega Ramos J; Bird CH; Mintern JD; Mangan MS; Villadangos J; Bird PI
Immunol Cell Biol; 2012 Oct; 90(9):841-51. PubMed ID: 22801574
[TBL] [Abstract][Full Text] [Related]
12. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
[TBL] [Abstract][Full Text] [Related]
13. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses.
Nouri-Shirazi M; Banchereau J; Bell D; Burkeholder S; Kraus ET; Davoust J; Palucka KA
J Immunol; 2000 Oct; 165(7):3797-803. PubMed ID: 11034385
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an immediate splenic precursor of CD8+ dendritic cells capable of inducing antiviral T cell responses.
Bedoui S; Prato S; Mintern J; Gebhardt T; Zhan Y; Lew AM; Heath WR; Villadangos JA; Segura E
J Immunol; 2009 Apr; 182(7):4200-7. PubMed ID: 19299718
[TBL] [Abstract][Full Text] [Related]
16. Antigen presentation by an immature myeloid dendritic cell line does not cause CTL deletion in vivo, but generates CD8+ central memory-like T cells that can be rescued for full effector function.
Dumortier H; van Mierlo GJ; Egan D; van Ewijk W; Toes RE; Offringa R; Melief CJ
J Immunol; 2005 Jul; 175(2):855-63. PubMed ID: 16002683
[TBL] [Abstract][Full Text] [Related]
17. Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
Keech CL; Pang KC; McCluskey J; Chen W
Eur J Immunol; 2010 Feb; 40(2):330-8. PubMed ID: 19950171
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
[TBL] [Abstract][Full Text] [Related]
19. Direct priming and cross-priming contribute differentially to the induction of CD8+ CTL following exposure to vaccinia virus via different routes.
Shen X; Wong SB; Buck CB; Zhang J; Siliciano RF
J Immunol; 2002 Oct; 169(8):4222-9. PubMed ID: 12370352
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: priming of CD8 T cell immunity to herpes simplex virus type 1 requires cognate TLR3 expression in vivo.
Davey GM; Wojtasiak M; Proietto AI; Carbone FR; Heath WR; Bedoui S
J Immunol; 2010 Mar; 184(5):2243-6. PubMed ID: 20124105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
